Strengthening global partnerships: Professor Amira Roess collaborates with international researchers to strengthen pathogen discovery   

In This Story

People Mentioned in This Story
Body

Since the first trade routes were established thousands of years ago, pathogens traveled along them spreading infectious diseases from once-isolated parts of the world. Today, global interconnectedness continues to rapidly spread infectious diseases across the world, transcending state, national, and continental boundaries. Consequently, the importance of understanding and preventing the transmission of pathogens relies on global cooperation and necessitates collaborative efforts among researchers.  

Amira Roess, George Mason University professor of public health, has been collaborating with colleagues in Bangladesh since 2002 on topics such as the impact of antibiotic use in animals on human health and the burden of pneumococcus, once a leading cause of neonatal infectious disease deaths in low-and-middle-income countries and once a leading cause of pneumonia in the United States. Pneumococcus infections have significantly decreased due to the introduction of vaccines globally.  

Drs. Janecko, Saha, and Roess
Drs. Nicol Janecko, Senjuti Saha, and Amira Roess

In 2018, colleagues from the United Kingdom joined the U.S.-Bangladesh collaboration when the team, led by Roess, received a $1.2 million grant from the Bill and Melinda Gates Foundation. With the grant, the team studied campylobacter, the leading bacterial cause of diarrheal diseases in the U.S. and Europe, which causes an estimated 400 million infections per year globally. 

“Collaboration across countries is critical to learn about and reduce the spread of infectious diseases. Universities play a crucial role in maintaining long-term global collaborations that withstand the constant changes in political alliances between nations,” said Roess. “Studying rapidly emerging infectious diseases requires that scientists from across the world work together and share data and technology. By uniting our efforts, we can protect each other against the spread of diseases, creating a global shield that transcends borders and protects the health and well-being of all." 

In 2023, Nicol Janecko from the Quadram Institute in the United Kingdom and Roess received a £50,000 Biotechnology and Biological Sciences Research Council United States Partnering Award to expand existing collaboration between researchers in the UK and the U.S. In January 2024, Janecko and Senjuti Saha visited Mason’s SciTech campus to share their knowledge and learn from other Mason researchers focused on discovering more about the transmission of infectious diseases. 

Saha and Janecko spoke with Mason faculty and student researchers about “Applying metagenomics to understanding complex transmission dynamics of zoonotic pathogens.” Saha spoke about the Child Health Research Foundation’s research and outreach on meningitis in Bangladesh and Janecko shared research about campylobacter.  

Saha and Janecko also met with Mason students and faculty who have common research interests, including Professor Ginny Espina, Professor Iosif Vaisman, Mason’s Institute for Biohealth innovation Executive Director Amy Adams, Professor Patrick Gillevet, and Associate Professor Aarthi Narayanan. The visiting researchers also toured Mason’s Biomedical Research Laboratory, Mason’s MicroBiome Analysis Center, Mason's Center for Applied Proteomics and Molecular Medicine, and Mason’s other public health laboratory facilities.